Works matching AU Pardoll, Drew


Results: 120
    1

    Combination anti-CXCR4 and anti-PD-1 immunotherapy provides survival benefit in glioblastoma through immune cell modulation of tumor microenvironment.

    Published in:
    Journal of Neuro-Oncology, 2019, v. 143, n. 2, p. 241, doi. 10.1007/s11060-019-03172-5
    By:
    • Wu, Adela;
    • Maxwell, Russell;
    • Xia, Yuanxuan;
    • Cardarelli, Pina;
    • Oyasu, Miho;
    • Belcaid, Zineb;
    • Kim, Eileen;
    • Hung, Alice;
    • Luksik, Andrew S.;
    • Garzon-Muvdi, Tomas;
    • Jackson, Christopher M.;
    • Mathios, Dimitrios;
    • Theodros, Debebe;
    • Cogswell, John;
    • Brem, Henry;
    • Pardoll, Drew M.;
    • Lim, Michael
    Publication type:
    Article
    2
    3

    Concepts of immunotherapy for glioma.

    Published in:
    Journal of Neuro-Oncology, 2015, v. 123, n. 3, p. 323, doi. 10.1007/s11060-015-1810-5
    By:
    • Patel, Mira;
    • Pardoll, Drew
    Publication type:
    Article
    4

    PD-1, PD-L1, PD-L2 expression in the chordoma microenvironment.

    Published in:
    Journal of Neuro-Oncology, 2015, v. 121, n. 2, p. 251, doi. 10.1007/s11060-014-1637-5
    By:
    • Mathios, Dimitrios;
    • Ruzevick, Jacob;
    • Jackson, Christopher;
    • Xu, Haiying;
    • Shah, Sagar;
    • Taube, Janis;
    • Burger, Peter;
    • McCarthy, Edward;
    • Quinones-Hinojosa, Alfredo;
    • Pardoll, Drew;
    • Lim, Michael
    Publication type:
    Article
    5

    The role of STAT3 activation in modulating the immune microenvironment of GBM.

    Published in:
    Journal of Neuro-Oncology, 2012, v. 110, n. 3, p. 359, doi. 10.1007/s11060-012-0981-6
    By:
    • See, Alfred;
    • Han, James;
    • Phallen, Jillian;
    • Binder, Zev;
    • Gallia, Gary;
    • Pan, Fan;
    • Jinasena, Dilini;
    • Jackson, Christopher;
    • Belcaid, Zineb;
    • Jeong, Sung;
    • Gottschalk, Chelsea;
    • Zeng, Jing;
    • Ruzevick, Jacob;
    • Nicholas, Sarah;
    • Kim, Young;
    • Albesiano, Emilia;
    • Pardoll, Drew;
    • Lim, Michael
    Publication type:
    Article
    6
    7
    8

    Tumor Frameshift Mutation Proportion Predicts Response to Immunotherapy in Mismatch Repair‐Deficient Prostate Cancer.

    Published in:
    Oncologist, 2021, v. 26, n. 2, p. e270, doi. 10.1002/onco.13601
    By:
    • Sena, Laura A.;
    • Fountain, Julia;
    • Isaacsson Velho, Pedro;
    • Lim, Su Jin;
    • Wang, Hao;
    • Nizialek, Emily;
    • Rathi, Nityam;
    • Nussenzveig, Roberto;
    • Maughan, Benjamin L.;
    • Velez, Miguel Gonzalez;
    • Ashkar, Ryan;
    • Larson, Amanda C.;
    • Pritchard, Colin C.;
    • Adra, Nabil;
    • Bryce, Alan H.;
    • Agarwal, Neeraj;
    • Pardoll, Drew M.;
    • Eshleman, James R.;
    • Lotan, Tamara L.;
    • Antonarakis, Emmanuel S.
    Publication type:
    Article
    9
    10

    A minimal gene set characterizes TIL specific for diverse tumor antigens across different cancer types.

    Published in:
    Nature Communications, 2025, v. 16, n. 1, p. 1, doi. 10.1038/s41467-024-55059-3
    By:
    • Zeng, Zhen;
    • Zhang, Tianbei;
    • Zhang, Jiajia;
    • Li, Shuai;
    • Connor, Sydney;
    • Zhang, Boyang;
    • Zhao, Yimin;
    • Wilson, Jordan;
    • Singh, Dipika;
    • Kulikauskas, Rima;
    • Church, Candice D.;
    • Pulliam, Thomas H.;
    • Jani, Saumya;
    • Nghiem, Paul;
    • Topalian, Suzanne L.;
    • Forde, Patrick M.;
    • Pardoll, Drew M.;
    • Ji, Hongkai;
    • Smith, Kellie N.
    Publication type:
    Article
    11
    12
    13
    14
    15
    16

    Re-engineered BCG overexpressing cyclic di-AMP augments trained immunity and exhibits improved efficacy against bladder cancer.

    Published in:
    Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-28509-z
    By:
    • Singh, Alok Kumar;
    • Praharaj, Monali;
    • Lombardo, Kara A.;
    • Yoshida, Takahiro;
    • Matoso, Andres;
    • Baras, Alex S.;
    • Zhao, Liang;
    • Srikrishna, Geetha;
    • Huang, Joy;
    • Prasad, Pankaj;
    • Powell, Jonathan D.;
    • Kates, Max;
    • McConkey, David;
    • Pardoll, Drew M.;
    • Bishai, William R.;
    • Bivalacqua, Trinity J.
    Publication type:
    Article
    17

    Structural engineering of chimeric antigen receptors targeting HLA-restricted neoantigens.

    Published in:
    Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-25605-4
    By:
    • Hwang, Michael S.;
    • Miller, Michelle S.;
    • Thirawatananond, Puchong;
    • Douglass, Jacqueline;
    • Wright, Katharine M.;
    • Hsiue, Emily Han-Chung;
    • Mog, Brian J.;
    • Aytenfisu, Tihitina Y.;
    • Murphy, Michael B.;
    • Aitana Azurmendi, P.;
    • Skora, Andrew D.;
    • Pearlman, Alexander H.;
    • Paul, Suman;
    • DiNapoli, Sarah R.;
    • Konig, Maximilian F.;
    • Bettegowda, Chetan;
    • Pardoll, Drew M.;
    • Papadopoulos, Nickolas;
    • Kinzler, Kenneth W.;
    • Vogelstein, Bert
    Publication type:
    Article
    18

    Comparing anti-tumor and anti-self immunity in a patient with melanoma receiving immune checkpoint blockade.

    Published in:
    Journal of Translational Medicine, 2024, v. 22, n. 1, p. 1, doi. 10.1186/s12967-024-04973-7
    By:
    • Chen, Shuming;
    • McMiller, Tracee L.;
    • Soni, Abha;
    • Succaria, Farah;
    • Sidhom, John-William;
    • Cappelli, Laura C.;
    • Casciola-Rosen, Livia A.;
    • Morales, Isaac R.;
    • Sankaran, Preethi;
    • Berger, Alan E.;
    • Deutsch, Julie Stein;
    • Zhu, Qingfeng C.;
    • Anders, Robert A.;
    • Hooper, Jody E.;
    • Pardoll, Drew M.;
    • Lipson, Evan J.;
    • Taube, Janis M.;
    • Topalian, Suzanne L.
    Publication type:
    Article
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31

    CCR2 and CCR5 co-inhibition modulates immunosuppressive myeloid milieu in glioma and synergizes with anti-PD-1 therapy.

    Published in:
    OncoImmunology, 2024, v. 13, n. 1, p. 1, doi. 10.1080/2162402X.2024.2338965
    By:
    • Pant, Ayush;
    • Hwa-Lin Bergsneider, Brandon;
    • Srivastava, Siddhartha;
    • Kim, Timothy;
    • Jain, Aanchal;
    • Bom, Sadhana;
    • Shah, Pavan;
    • Kannapadi, Nivedha;
    • Patel, Kisha;
    • Choi, John;
    • Cho, Kwang Bog;
    • Verma, Rohit;
    • Yu-Ju Wu, Caren;
    • Brem, Henry;
    • Tyler, Betty;
    • Pardoll, Drew M.;
    • Jackson, Christina;
    • Lim, Michael
    Publication type:
    Article
    32
    33

    Contrasting impact of corticosteroids on anti-PD-1 immunotherapy efficacy for tumor histologies located within or outside the central nervous system.

    Published in:
    OncoImmunology, 2018, v. 7, n. 12, p. 1, doi. 10.1080/2162402X.2018.1500108
    By:
    • Maxwell, Russell;
    • Luksik, Andrew S.;
    • Garzon-Muvdi, Tomas;
    • Hung, Alice L.;
    • Kim, Eileen S.;
    • Wu, Adela;
    • Xia, Yuanxuan;
    • Belcaid, Zineb;
    • Gorelick, Noah;
    • Choi, John;
    • Theodros, Debebe;
    • Jackson, Christopher M.;
    • Mathios, Dimitrios;
    • Ye, Xiaobu;
    • Tran, Phuoc T.;
    • Redmond, Kristin J.;
    • Brem, Henry;
    • Pardoll, Drew M.;
    • Kleinberg, Lawrence R.;
    • Lim, Michael
    Publication type:
    Article
    34

    TIGIT and PD-1 dual checkpoint blockade enhances antitumor immunity and survival in GBM.

    Published in:
    OncoImmunology, 2018, v. 7, n. 8, p. 1, doi. 10.1080/2162402X.2018.1466769
    By:
    • Hung, Alice L.;
    • Maxwell, Russell;
    • Belcaid, Zineb;
    • Mathios, Dimitrios;
    • Luksik, Andrew S.;
    • Kim, Eileen;
    • Wu, Adela;
    • Xia, Yuanxuan;
    • Garzon-Muvdi, Tomas;
    • Jackson, Christopher;
    • Ye, Xiaobu;
    • Tyler, Betty;
    • Brem, Henry;
    • Lim, Michael;
    • Theodros, Debebe;
    • Pardoll, Drew M.;
    • Selby, Mark;
    • Korman, Alan;
    • Barnhart, Bryan;
    • Park, Su-Myeong
    Publication type:
    Article
    35
    36

    Anti–PD-1 antitumor immunity is enhanced by local and abrogated by systemic chemotherapy in GBM.

    Published in:
    Science Translational Medicine, 2016, v. 8, n. 370, p. 1, doi. 10.1126/scitranslmed.aag2942
    By:
    • Mathios, Dimitrios;
    • Kim, Jennifer E.;
    • Mangraviti, Antonella;
    • Phallen, Jillian;
    • Chul-Kee Park;
    • Jackson, Christopher M.;
    • Garzon-Muvdi, Tomas;
    • Kim, Eileen;
    • Theodros, Debebe;
    • Polanczyk, Magdalena;
    • Martin, Allison M.;
    • Ian Suk;
    • Xiaobu Ye;
    • Tyler, Betty;
    • Bettegowda, Chetan;
    • Brem, Henry;
    • Pardoll, Drew M.;
    • Lim, Michael
    Publication type:
    Article
    37

    Adoptive transfer of activated marrow-infiltrating lymphocytes induces measurable antitumor immunity in the bone marrow in multiple myeloma.

    Published in:
    Science Translational Medicine, 2015, v. 7, n. 288, p. 1, doi. 10.1126/scitranslmed.aaa7014
    By:
    • Noonan, Kimberly A.;
    • Huff, Carol A.;
    • Davis, Janice;
    • Lemas, M. Victor;
    • Fiorino, Susan;
    • Bitzan, Jeffrey;
    • Ferguson, Anna;
    • Emerling, Amy;
    • Luznik, Leo;
    • Matsui, William;
    • Powell, Jonathan;
    • Fuchs, Ephraim;
    • Rosner, Gary L.;
    • Epstein, Caroline;
    • Rudraraju, Lakshmi;
    • Ambinder, Richard F.;
    • Jones, Richard J.;
    • Pardoll, Drew;
    • Borrello, Ivan
    Publication type:
    Article
    38

    STING agonist formulated cancer vaccines can cure established tumors resistant to PD-1 blockade.

    Published in:
    Science Translational Medicine, 2015, v. 7, n. 283, p. 1, doi. 10.1126/scitranslmed.aaa4306
    By:
    • Juan Fu;
    • Kanne, David B.;
    • Leong, Meredith;
    • Glickman, Laura Hix;
    • McWhirter, Sarah M.;
    • Lemmens, Edward;
    • Mechette, Ken;
    • Leong, Justin J.;
    • Lauer, Peter;
    • Weiqun Liu;
    • Sivick, Kelsey E.;
    • Qi Zeng;
    • Soares, Kevin C.;
    • Lei Zheng;
    • Portnoy, Daniel A.;
    • Woodward, Joshua J.;
    • Pardoll, Drew M.;
    • Dubensky Jr., Thomas W.;
    • Young Kim
    Publication type:
    Article
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50